INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $57,036,596 | +1.1% | 57,791,000 | 0.0% | 1.27% | +8.9% |
| Q4 2022 | $56,418,464 | +0.6% | 57,791,000 | 0.0% | 1.17% | +4.6% |
| Q3 2022 | $56,098,000 | -0.1% | 57,791,000 | 0.0% | 1.12% | -3.5% |
| Q2 2022 | $56,158,000 | +6.0% | 57,791,000 | 0.0% | 1.16% | -2.3% |
| Q1 2022 | $52,992,000 | -2.6% | 57,791,000 | 0.0% | 1.18% | +3.9% |
| Q4 2021 | $54,417,000 | +4.4% | 57,791,000 | 0.0% | 1.14% | +12.2% |
| Q3 2021 | $52,121,000 | +0.4% | 57,791,000 | 0.0% | 1.02% | +10.3% |
| Q2 2021 | $51,920,000 | +9.2% | 57,791,000 | 0.0% | 0.92% | -7.7% |
| Q1 2021 | $47,537,000 | +3.9% | 57,791,000 | 0.0% | 1.00% | +10.5% |
| Q4 2020 | $45,738,000 | -1.7% | 57,791,000 | 0.0% | 0.90% | -20.2% |
| Q3 2020 | $46,521,000 | +7.2% | 57,791,000 | 0.0% | 1.13% | -10.4% |
| Q2 2020 | $43,410,000 | -7.3% | 57,791,000 | 0.0% | 1.26% | -14.9% |
| Q1 2020 | $46,815,000 | -19.6% | 57,791,000 | 0.0% | 1.49% | -20.1% |
| Q4 2019 | $58,256,000 | +17.6% | 57,791,000 | 0.0% | 1.86% | -7.9% |
| Q3 2019 | $49,530,000 | -3.6% | 57,791,000 | 0.0% | 2.02% | +9.4% |
| Q2 2019 | $51,380,000 | -10.2% | 57,791,000 | 0.0% | 1.85% | -15.8% |
| Q1 2019 | $57,201,000 | +7.9% | 57,791,000 | 0.0% | 2.19% | +3.3% |
| Q4 2018 | $53,020,000 | +46.3% | 57,791,000 | +60.5% | 2.12% | +63.5% |
| Q3 2018 | $36,248,000 | +14.7% | 36,000,000 | 0.0% | 1.30% | +16.9% |
| Q2 2018 | $31,598,000 | +10.5% | 36,000,000 | 0.0% | 1.11% | +12.0% |
| Q1 2018 | $28,596,000 | -1.0% | 36,000,000 | 0.0% | 0.99% | -12.8% |
| Q4 2017 | $28,879,000 | -27.2% | 36,000,000 | -29.4% | 1.14% | -36.4% |
| Q3 2017 | $39,674,000 | +80.5% | 51,000,000 | +126.7% | 1.79% | +52.3% |
| Q2 2017 | $21,983,000 | -44.4% | 22,500,000 | -47.1% | 1.17% | -23.1% |
| Q1 2017 | $39,540,000 | – | 42,500,000 | – | 1.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|